These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37189731)

  • 21. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
    Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
    J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role and Dysregulation of miRNA in Patients with Parkinson's Disease.
    Salemi M; Marchese G; Lanza G; Cosentino FII; Salluzzo MG; Schillaci FA; Ventola GM; Cordella A; Ravo M; Ferri R
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-4722-5p and microRNA-615-3p serve as potential biomarkers for Alzheimer's disease.
    Liu Y; Xu Y; Yu M
    Exp Ther Med; 2022 Mar; 23(3):241. PubMed ID: 35222718
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microarray microRNA profiling of urinary exosomes in a 5XFAD mouse model of Alzheimer's disease.
    Song Z; Qu Y; Xu Y; Zhang L; Zhou L; Han Y; Zhao W; Yu P; Zhang Y; Li X; Qin C
    Animal Model Exp Med; 2021 Sep; 4(3):233-242. PubMed ID: 34557649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.
    Herrera-Espejo S; Santos-Zorrozua B; Álvarez-González P; Lopez-Lopez E; Garcia-Orad Á
    Mol Neurobiol; 2019 Dec; 56(12):8376-8391. PubMed ID: 31240600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A compound downregulation of SRRM2 and miR-27a-3p with upregulation of miR-27b-3p in PBMCs of Parkinson's patients is associated with the early stage onset of disease.
    Fazeli S; Motovali-Bashi M; Peymani M; Hashemi MS; Etemadifar M; Nasr-Esfahani MH; Ghaedi K
    PLoS One; 2020; 15(11):e0240855. PubMed ID: 33171483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
    Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
    Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computational Prediction of Alzheimer's and Parkinson's Disease MicroRNAs in Domestic Animals.
    Wang HY; Lin ZL; Yu XF; Bao Y; Cui XS; Kim NH
    Asian-Australas J Anim Sci; 2016 Jun; 29(6):782-92. PubMed ID: 26954182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulatory miR-223-3p Discriminates Between Parkinson's and Alzheimer's Patients.
    Mancuso R; Agostini S; Hernis A; Zanzottera M; Bianchi A; Clerici M
    Sci Rep; 2019 Jun; 9(1):9393. PubMed ID: 31253822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating micro-RNAs Differentially Expressed in Korean Alzheimer's Patients With Brain Aβ Accumulation Activate Amyloidogenesis.
    Mankhong S; Kim S; Moon S; Choi SH; Kwak HB; Park DH; Shah P; Lee PH; Yang SW; Kang JH
    J Gerontol A Biol Sci Med Sci; 2023 Feb; 78(2):292-303. PubMed ID: 35532940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.
    Mo M; Xiao Y; Huang S; Cen L; Chen X; Zhang L; Luo Q; Li S; Yang X; Lin X; Xu P
    Oncotarget; 2017 Jan; 8(1):15-28. PubMed ID: 27965467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analyses identify differentially expressed micrornas in Parkinson's disease.
    Schulz J; Takousis P; Wohlers I; Itua IOG; Dobricic V; Rücker G; Binder H; Middleton L; Ioannidis JPA; Perneczky R; Bertram L; Lill CM
    Ann Neurol; 2019 Jun; 85(6):835-851. PubMed ID: 30990912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
    Kumar S; Reddy PH
    Biochim Biophys Acta; 2016 Sep; 1862(9):1617-27. PubMed ID: 27264337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrated approach to unravel a putative crosstalk network in Alzheimer's disease and Parkinson's disease.
    Bisht I; Ambasta RK; Kumar P
    Neuropeptides; 2020 Oct; 83():102078. PubMed ID: 32807513
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic Review and Bioinformatic Analysis of microRNA Expression in Autism Spectrum Disorder Identifies Pathways Associated With Cancer, Metabolism, Cell Signaling, and Cell Adhesion.
    Huang ZX; Chen Y; Guo HR; Chen GF
    Front Psychiatry; 2021; 12():630876. PubMed ID: 34744804
    [No Abstract]   [Full Text] [Related]  

  • 36. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
    Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
    J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature.
    Redenšek Trampuž S; Vogrinc D; Goričar K; Dolžan V
    Front Mol Neurosci; 2023; 16():1123955. PubMed ID: 37008787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of stress-related microRNA biomarkers in type 2 diabetes mellitus: A systematic review and meta-analysis.
    Liang YZ; Li JJ; Xiao HB; He Y; Zhang L; Yan YX
    J Diabetes; 2020 Sep; 12(9):633-644. PubMed ID: 29341487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative study of microRNA profiling in one Chinese Family with PSEN1 G378E mutation.
    Lv Z; Hu L; Yang Y; Zhang K; Sun Z; Zhang J; Zhang L; Hao Y
    Metab Brain Dis; 2018 Oct; 33(5):1711-1720. PubMed ID: 29961914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic value of microRNAs in asbestos exposure and malignant mesothelioma: systematic review and qualitative meta-analysis.
    Micolucci L; Akhtar MM; Olivieri F; Rippo MR; Procopio AD
    Oncotarget; 2016 Sep; 7(36):58606-58637. PubMed ID: 27259231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.